Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma

Table 1

Patient characteristics.

Patient characteristics	Number (𝑁)
Total	15
Diagnosis:
Rhabdomyosarcoma	6
Ewing’s sarcoma	5
Synovial sarcoma	2
Leiomyosarcoma	1
DSRCT	1
Gender:
Male	8
Female	7
Age:
Age at diagnosis (years)	mean: 30, (range: 16–56)
Age at relapse (years)	mean: 31, (range: 19–57)
Topotecan/cyclophosphamide
2nd line therapy	12
3rd line therapy	3
Time to 1st relapse (months)	mean: 21, (range: 9–52)